Studies of phosphoproteomic changes induced by nucleophosmin-anaplastic lymphoma kinase (ALK) highlight deregulation of tumor necrosis factor (TNF)/Fas/TNF-related apoptosis-induced ligand signaling pathway in ALK-positive anaplastic large cell lymphoma

Molecular and Cellular Proteomics

Volumn 9, Issue 7, 2010, Pages 1616-1632

  Wu, Fang ^a   Wang, Peng ^a   Zhang, Jingdong ^a   Young, Leah C ^a   Lai, Raymond ^a   Li, Liang ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; DOXORUBICIN; FAS ANTIGEN; NUCLEOPHOSMIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN TRAP1; PROTEASOME; PROTEIN TYROSINE KINASE; RECEPTOR INTERACTING PROTEIN 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UBIQUITIN; UNCLASSIFIED DRUG; P80(NPM-ALK) PROTEIN; PROTEOME; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOINFORMATICS; CELL DEATH; CONTROLLED STUDY; DEREGULATION; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; MODULATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; AMINO ACID SEQUENCE; CELL LINE; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANTIGENS, CD95; CELL LINE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEIN-TYROSINE KINASES; PROTEOME; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954718615     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M000153-MCP201     Document Type: Article

References (80)

1. Delsol, G., Ralfkiaer, E., Stein, H., Wright, D., and Jaffe, E. (2001) Pathology and Genetics Tumors of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumors, IARC Press, Lyon, France
2. Stein, H., Foss, H. D., Dürkop, H., Marafioti, T., Delsol, G., Pulford, K., Pileri, S., and Falini, B. (2000) CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96, 3681-3695
3. Mason, D. Y., Bastard, C., Rimokh, R., Dastugue, N., Huret, J. L., Kristoffersson, U., Magaud, J. P., Nezelof, C., Tilly, H., Vannier, J. P., Hemet, J., and Warnke, R. (1990) CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br. J. Haematol. 74, 161-168
4. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K., Shapiro, D. N., Look, A. T., and Saltman, D. L. (1995) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 267, 316-317
5. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., and Look, A. T. (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263, 1281-1284
6. Benz-Lemoine, E., Brizard, A., Huret, J. L., Babin, P., Guilhot, F., Couet, D., and Tanzer, J. (1988) Malignant histiocytosis: a specific t(2;5)(p23;q35) translocation? Review of the literature. Blood 72, 1045-1047
7. Fischer, P., Nacheva, E., Mason, D. Y., Sherrington, P. D., Hoyle, C., Hayhoe, F. G., and Karpas, A. (1988) A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 72, 234-240
8. Bai, R. Y., Ouyang, T., Miething, C., Morris, S. W., Peschel, C., and Duyster, J. (2000) Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway. Blood 96, 4319-4327
9. Slupianek, A., Nieborowska-Skorska, M., Hoser, G., Morrione, A., Majewski, M., Xue, L., Morris, S. W., Wasik, M. A., and Skorski, T. (2001) Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis. Cancer Res. 61, 2194-2199
10. Amin, H. M., McDonnell, T. J., Ma, Y., Lin, Q., Fujio, Y., Kunisada, K., Leventaki, V., Das, P., Rassidakis, G. Z., Cutler, C., Medeiros, L. J., and Lai, R. (2004) Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene 23, 5426-5434
11. Kutok, J. L., and Aster, J. C. (2002) Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. J. Clin. Oncol. 20, 3691-3702 (Pubitemid 34983230)
12. Marzec, M., Kasprzycka, M., Liu, X., El-Salem, M., Halasa, K., Raghunath, P. N., Bucki, R., Wlodarski, P., and Wasik, M. A. (2007) Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway. Oncogene 26, 5606-5614 (Pubitemid 47267838)
13. Gu, L., Gao, J., Li, Q., Zhu, Y. P., Jia, C. S., Fu, R. Y., Chen, Y., Liao, Q. K., and Ma, Z. (2008) Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis. Leukemia 22, 2091-2096
14. Marzec, M., Kasprzycka, M., Liu, X., Raghunath, P. N., Wlodarski, P., and Wasik, M. A. (2007) Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Oncogene 26, 813-821
15. Turner, S. D., Yeung, D., Hadfield, K., Cook, S. J., and Alexander, D. R. (2007) The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms. Cell. Signal. 19, 740-747
16. Boccalatte, F. E., Voena, C., Riganti, C., Bosia, A., D'Amico, L., Riera, L., Cheng, M., Ruggeri, B., Jensen, O. N., Goss, V. L., Lee, K., Nardone, J., Rush, J., Polakiewicz, R. D., Comb, M. J., Chiarle, R., and Inghirami, G. (2009) The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPMALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL. Blood 113, 2776-2790
17. Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X. M., Polakiewicz, R. D., and Comb, M. J. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94-101
18. Leventaki, V., Drakos, E., Medeiros, L. J., Lim, M. S., Elenitoba-Johnson, K. S., Claret, F. X., and Rassidakis, G. Z. (2007) NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma. Blood 110, 1621-1630 (Pubitemid 47443980)
19. Ouyang, T., Bai, R. Y., Bassermann, F., von Klitzing, C., Klumpen, S., Miething, C., Morris, S. W., Peschel, C., and Duyster, J. (2003) Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA). J. Biol. Chem. 278, 30028-30036 (Pubitemid 36962393)
20. Wu, F., Wang, P., Young, L. C., Lai, R., and Li, L. (2009) Proteome-wide identification of novel binding partners to the oncogenic fusion gene protein, NPM-ALK, using tandem affinity purification and mass spectrometry. Am. J. Pathol. 174, 361-370
21. Ficarro, S. B., McCleland, M. L., Stukenberg, P. T., Burke, D. J., Ross, M. M., Shabanowitz, J., Hunt, D. F., and White, F. M. (2002) Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 20, 301-305
22. Carrascal, M., Ovelleiro, D., Casas, V., Gay, M., and Abian, J. (2008) Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment. J. Proteome Res. 7, 5167-5176
23. Villén, J., Beausoleil, S. A., Gerber, S. A., and Gygi, S. P. (2007) Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. U.S.A. 104, 1488-1493 (Pubitemid 46214617)
24. Thingholm, T. E., Jørgensen, T. J., Jensen, O. N., and Larsen, M. R. (2006) Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat. Protoc. 1, 1929-1935
25. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., and Jørgensen, T. J. (2005) Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 4, 873-886 (Pubitemid 41309146)
26. Pinkse, M. W., Uitto, P. M., Hilhorst, M. J., Ooms, B., and Heck, A. J. (2004) Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal. Chem. 76, 3935-3943 (Pubitemid 38943662)
27. Marcantonio, M., Trost, M., Courcelles, M., Desjardins, M., and Thibault, P. (2008) Combined enzymatic and data mining approaches for comprehensive phosphoproteome analyses: application to cell signaling events of interferon-gamma-stimulated macrophages. Mol. Cell. Proteomics 7, 645-660 (Pubitemid 351597477)
28. Trost, M., English, L., Lemieux, S., Courcelles, M., Desjardins, M., and Thibault, P. (2009) The phagosomal proteome in interferon-gamma-activated macrophages. Immunity 30, 143-154
29. Trinidad, J. C., Specht, C. G., Thalhammer, A., Schoepfer, R., and Burlingame, A. L. (2006) Comprehensive identification of phosphorylation sites in postsynaptic density preparations. Mol. Cell. Proteomics 5, 914-922 (Pubitemid 43792800)
30. Oda, Y., Nagasu, T., and Chait, B. T. (2001) Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19, 379-382 (Pubitemid 32275350)
31. Simon, E. S., Young, M., Chan, A., Bao, Z. Q., and Andrews, P. C. (2008) Improved enrichment strategies for phosphorylated peptides on titanium dioxide using methyl esterification and pH gradient elution. Anal. Biochem. 377, 234-242
32. Salomon, A. R., Ficarro, S. B., Brill, L. M., Brinker, A., Phung, Q. T., Ericson, C., Sauer, K., Brock, A., Horn, D. M., Schultz, P. G., and Peters, E. C. (2003) Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 100, 443-448
33. Munton, R. P., Tweedie-Cullen, R., Livingstone-Zatchej, M., Weinandy, F., Waidelich, M., Longo, D., Gehrig, P., Potthast, F., Rutishauser, D., Gerrits, B., Panse, C., Schlapbach, R., and Mansuy, I. M. (2007) Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations. Mol. Cell. Proteomics 6, 283-293
34. Smolka, M. B., Albuquerque, C. P., Chen, S. H., Schmidt, K. H., Wei, X. X., Kolodner, R. D., and Zhou, H. (2005) Dynamic changes in protein-protein interaction and protein phosphorylation probed with amine-reactive isotope tag. Mol. Cell. Proteomics 4, 1358-1369
35. McNulty, D. E., and Annan, R. S. (2008) Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol. Cell. Proteomics 7, 971-980
36. Ballif, B. A., Carey, G. R., Sunyaev, S. R., and Gygi, S. P. (2008) Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J. Proteome Res. 7, 311-318
37. Zheng, H., Hu, P., Quinn, D. F., and Wang, Y. K. (2005) Phosphotyrosine proteomic study of interferon alpha signaling pathway using a combination of immunoprecipitation and immobilized metal affinity chromatography. Mol. Cell. Proteomics 4, 721-730 (Pubitemid 40879601)
38. Zhang, Y., Wolf-Yadlin, A., Ross, P. L., Pappin, D. J., Rush, J., Lauffenburger, D. A., and White, F. M. (2005) Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 4, 1240-1250 (Pubitemid 41448712)
39. Boersema, P. J., Foong, L. Y., Ding, V. M., Lemeer, S., van Breukelen, B., Philp, R., Boekhorst, J., Snel, B., den Hertog, J., Choo, A. B., and Heck, A. J. (2010) In-depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immunoaffinity purification and stable isotope dimethyl labeling. Mol. Cell. Proteomics 9, 84-99
40. Bai, R. Y., Dieter, P., Peschel, C., Morris, S. W., and Duyster, J. (1998) Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol. Cell. Biol. 18, 6951-6961 (Pubitemid 28533016)
41. Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E., and Inghirami, G. (2002) Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 21, 1038-1047 (Pubitemid 34174516)
42. Tartari, C. J., Gunby, R. H., Coluccia, A. M., Sottocornola, R., Cimbro, B., Scapozza, L., Donella-Deana, A., Pinna, L. A., and Gambacorti-Passerini, C. (2008) Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase. J. Biol. Chem. 283, 3743-3750
43. Wang, P., Wu, F., Ma, Y., Li, L., Lai, R., and Young, L. C. (2010) Functional characterization of the kinase activation loop in nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) using tandem affinity purification and liquid chromatography-mass spectrometry. J. Biol. Chem. 285, 95-103
44. Morgan, R., Smith, S. D., Hecht, B. K., Christy, V., Mellentin, J. D., Warnke, R., and Cleary, M. L. (1989) Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73, 2155-2164 (Pubitemid 19179549)
45. Wang, N., Xie, C., Young, J. B., and Li, L. (2009) Off-line two-dimensional liquid chromatography with maximized sample loading to reversed-phase liquid chromatography-electrospray ionization tandem mass spectrometry for shotgun proteome analysis. Anal. Chem. 81, 1049-1060
46. Wang, N., and Li, L. (2008) Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis. Anal. Chem. 80, 4696-4710 (Pubitemid 351842350)
47. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214
48. Ghobrial, I. M., McCormick, D. J., Kaufmann, S. H., Leontovich, A. A., Loegering, D. A., Dai, N. T., Krajnik, K. L., Stenson, M. J., Melhem, M. F., Novak, A. J., Ansell, S. M., and Witzig, T. E. (2005) Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 105, 3722-3730
49. Smith, L., Watson, M. B., O'Kane, S. L., Drew, P. J., Lind, M. J., and Cawkwell, L. (2006) The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol. Cancer Ther. 5, 2115-2120
50. Shi, X., Franko, B., Frantz, C., Amin, H. M., and Lai, R. (2006) JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells. Br. J. Haematol. 135, 26-32
51. Amin, H. M., Medeiros, L. J., Ma, Y., Feretzaki, M., Das, P., Leventaki, V., Rassidakis, G. Z., O'Connor, S. L., McDonnell, T. J., and Lai, R. (2003) Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene 22, 5399-5407
52. Bard, J. D., Gelebart, P., Anand, M., Amin, H. M., and Lai, R. (2008) Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia 22, 1595-1603
53. Zhang, Z., and Zhang, R. (2008) Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J. 27, 852-864
54. Feng, X., Guo, Z., Nourbakhsh, M., Hauser, H., Ganster, R., Shao, L., and Geller, D. A. (2002) Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Proc. Natl. Acad. Sci. U.S.A. 99, 14212-14217
55. Xie, X., Wang, Z., and Chen, Y. (2007) Association of LKB1 with a WD-repeat protein WDR6 is implicated in cell growth arrest and p27(Kip1) induction. Mol. Cell. Biochem. 301, 115-122
56. Kimura, S. H., Tsuruga, H., Yabuta, N., Endo, Y., and Nojima, H. (1997) Structure, expression, and chromosomal localization of human GAK. Genomics 44, 179-187 (Pubitemid 27415542)
57. Greener, T., Zhao, X., Nojima, H., Eisenberg, E., and Greene, L. E. (2000) Role of cyclin G-associated kinase in uncoating clathrin-coated vesicles from non-neuronal cells. J. Biol. Chem. 275, 1365-1370
58. Byrd, D. A., Sweet, D. J., Panté, N., Konstantinov, K. N., Guan, T., Saphire, A. C., Mitchell, P. J., Cooper, C. S., Aebi, U., and Gerace, L. (1994) Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. J. Cell Biol. 127, 1515-1526
59. Nühse, T. S., Stensballe, A., Jensen, O. N., and Peck, S. C. (2003) Largescale analysis of in vivo phosphorylated membrane proteins by immobilized metal ion affinity chromatography and mass spectrometry. Mol. Cell. Proteomics 2, 1234-1243
60. Tsai, C. F., Wang, Y. T., Chen, Y. R., Lai, C. Y., Lin, P. Y., Pan, K. T., Chen, J. Y., Khoo, K. H., and Chen, Y. J. (2008) Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics. J. Proteome Res. 7, 4058-4069
61. Kokubu, M., Ishihama, Y., Sato, T., Nagasu, T., and Oda, Y. (2005) Specificity of immobilized metal affinity-based IMAC/C18 tip enrichment of phosphopeptides for protein phosphorylation analysis. Anal. Chem. 77, 5144-5154
62. Wang, P., Zhang, J., Bellail, A., Jiang, W., Hugh, J., Kneteman, N. M., and Hao, C. (2007) Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Cell. Signal. 19, 2237-2246
63. Wang, P., Song, J. H., Song, D. K., Zhang, J., and Hao, C. (2006) Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Cell. Signal. 18, 1528-1535
64. Sethi, G., Sung, B., and Aggarwal, B. B. (2008) TNF: a master switch for inflammation to cancer. Front. Biosci. 13, 5094-5107
65. Williams, G. M. (2008) Antitumor necrosis factor-alpha therapy and potential cancer inhibition. Eur. J. Cancer Prev. 17, 169-177
66. Devin, A., Lin, Y., and Liu, Z. G. (2003) The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep. 4, 623-627
67. Meylan, E., and Tschopp, J. (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem. Sci. 30, 151-159
68. Song, H. Y., Dunbar, J. D., Zhang, Y. X., Guo, D., and Donner, D. B. (1995) Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 270, 3574-3581
69. Pridgeon, J. W., Olzmann, J. A., Chin, L. S., and Li, L. (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 5, e172
70. Brill, L. M., Salomon, A. R., Ficarro, S. B., Mukherji, M., Stettler-Gill, M., and Peters, E. C. (2004) Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal. Chem. 76, 2763-2772
71. Zhang, Q., Raghunath, P. N., Xue, L., Majewski, M., Carpentieri, D. F., Odum, N., Morris, S., Skorski, T., and Wasik, M. A. (2002) Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J. Immunol. 168, 466-474
72. Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., and Yamamoto, T. (1996) Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. U.S.A. 93, 4181-4186
73. Voena, C., Conte, C., Ambrogio, C., Boeri Erba, E., Boccalatte, F., Mohammed, S., Jensen, O. N., Palestro, G., Inghirami, G., and Chiarle, R. (2007) The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration. Cancer Res. 67, 4278-4286
74. Ruchatz, H., Coluccia, A. M., Stano, P., Marchesi, E., and Gambacorti-Passerini, C. (2003) Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells. Exp. Hematol. 31, 309-315
75. Nieborowska-Skorska, M., Slupianek, A., Xue, L., Zhang, Q., Raghunath, P. N., Hoser, G., Wasik, M. A., Morris, S. W., and Skorski, T. (2001) Role of signal transducer and activator of transcription 5 in nucleophosmin/anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells. Cancer Res. 61, 6517-6523
76. Fawal, M., Armstrong, F., Ollier, S., Dupont, H., Touriol, C., Monsarrat, B., Delsol, G., Payrastre, B., and Morello, D. (2006) A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. Blood 108, 2780-2788
77. Cussac, D., Greenland, C., Roche, S., Bai, R. Y., Duyster, J., Morris, S. W., Delsol, G., Allouche, M., and Payrastre, B. (2004) Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Blood 103, 1464-1471
78. Galietta, A., Gunby, R. H., Redaelli, S., Stano, P., Carniti, C., Bachi, A., Tucker, P. W., Tartari, C. J., Huang, C. J., Colombo, E., Pulford, K., Puttini, M., Piazza, R. G., Ruchatz, H., Villa, A., Donella-Deana, A., Marin, O., Perrotti, D., and Gambacorti-Passerini, C. (2007) NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic largecell lymphoma. Blood 110, 2600-2609
79. Colomba, A., Courilleau, D., Ramel, D., Billadeau, D. D., Espinos, E., Delsol, G., Payrastre, B., and Gaits-Iacovoni, F. (2008) Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas. Oncogene 27, 2728-2736
80. Shi, P., Lai, R., Lin, Q., Iqbal, A. S., Young, L. C., Kwak, L. W., Ford, R. J., and Amin, H. M. (2009) IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells. Blood 114, 360-370